866-997-4948(US-Canada Toll Free)

Growth Hormone Deficiency (GHD) - Epidemiology Forecast To 2023

Published By :

DelveInsight

Published Date : Jan 2017

Category :

Pharmaceutical

No. of Pages : 60 Pages

DelveInsight Growth Hormone Deficiency (GHD) - Epidemiology Forecast To 2023 provides an overview of the epidemiology trends of Growth Hormone Deficiency (GHD) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Growth Hormone Deficiency (GHD) prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Growth Hormone Deficiency (GHD). The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.

Please note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope of the Report
The Report includes the prevalent population and how will it change over the next eight years.
Prevalent or incident cases segmented by age and sex.
Coverage of key Growth Hormone Deficiency (GHD) subpopulations and its prevalent or incident cases
The key differences in epidemiology patterns across the seven market segments

Key Coverage and Benefits
The report will help in developing business strategies by understanding the trends shaping and driving the global Growth Hormone Deficiency (GHD) market.
Identifying prevalent patient populations as well as risk factors in the global Growth Hormone Deficiency (GHD) market will help to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the best opportunities for Growth Hormone Deficiency (GHD) therapeutics in each of the markets covered.

1. Report Introduction
2. Snapshot of Total Prevalent or Incident cases by 7 MM
3. Executive Summary
Key Findings
4. Growth Hormone Deficiency (GHD)Overview
Growth Hormone Deficiency (GHD) Definition
Pathophysiology
Symptoms
Etiology
5. Risk Factors Associated with Growth Hormone Deficiency (GHD)
6. Disease Burden & Unmet Need in the Market
7. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2013-2023
Prevalent & Incident Cases by Category-2013-2023
o Age-Specific Prevalent/ Incident Cases of Growth Hormone Deficiency (GHD)
o Sex-Specific Prevalent/Incident Cases of Growth Hormone Deficiency (GHD)
o Disease Type Specific Prevalent/Incident Cases of Growth Hormone Deficiency (GHD)
Prevalent & Incident Cases by 7 MM-2013-2023
o Growth Hormone Deficiency (GHD) Epidemiology of United States-2023
o Growth Hormone Deficiency (GHD) Epidemiology of United Kingdom-2023
o Growth Hormone Deficiency (GHD) Epidemiology of Germany-2023
o Growth Hormone Deficiency (GHD) Epidemiology of France-2023
o Growth Hormone Deficiency (GHD) Epidemiology of Spain-2023
o Growth Hormone Deficiency (GHD) Epidemiology of Italy-2023
o Growth Hormone Deficiency (GHD) Epidemiology of Japan-2023
8. Key Takeaways
9. Appendix
10. Report Methodology
11. Consulting Services
12. Disclaimer
13. About Us

List of Table

Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Growth Hormone Deficiency (GHD) Global Epidemiology, (2013-2023)
Table 6: Prevalent Cases of Growth Hormone Deficiency (GHD) (Ages =XX Years), US (2013-2023)
Table 7: Prevalent Cases of Growth Hormone Deficiency (GHD) By Sex (Males & Females), US (2013-2023)
Table 8: Prevalent Cases By Growth Hormone Deficiency (GHD) Sub-population, US (2013-2023)
Table 9: Prevalent Cases of Growth Hormone Deficiency (GHD) (Ages =XX Years), United Kingdom (2013-2023)
Table 10: Prevalent Cases of Growth Hormone Deficiency (GHD) By Sex (Males & Females), United Kingdom (2013-2023)
Table 11: Prevalent Cases By Growth Hormone Deficiency (GHD) Sub-population, United Kingdom (2013-2023)
Table 12: Prevalent Cases of Growth Hormone Deficiency (GHD) (Ages =XX Years), Germany (2013-2023)
Table 13: Prevalent Cases of Growth Hormone Deficiency (GHD) By Sex (Males & Females), Germany (2013-2023)
Table 14: Prevalent Cases By Growth Hormone Deficiency (GHD) Sub-population, Germany (2013-2023)
Table 15: Prevalent Cases of Growth Hormone Deficiency (GHD) (Ages =XX Years), France (2013-2023)
Table 16: Prevalent Cases of Growth Hormone Deficiency (GHD) By Sex (Males & Females), France (2013-2023)
Table 17: Prevalent Cases By Growth Hormone Deficiency (GHD) Sub-population, France (2013-2023)
Table 18: Prevalent Cases of Growth Hormone Deficiency (GHD) (Ages =XX Years), Italy (2013-2023)
Table 19: Prevalent Cases of Growth Hormone Deficiency (GHD) By Sex (Males & Females), Italy (2013-2023)
Table 20: Prevalent Cases By Growth Hormone Deficiency (GHD) Sub-population, Italy (2013-2023)
Table 21: Prevalent Cases of Growth Hormone Deficiency (GHD) (Ages =XX Years), Spain (2013-2023)
Table 22: Prevalent Cases of Growth Hormone Deficiency (GHD) By Sex (Males & Females), Spain (2013-2023)
Table 23: Prevalent Cases By Growth Hormone Deficiency (GHD) Sub-population, Spain (2013-2023)
Table 24: Prevalent Cases of Growth Hormone Deficiency (GHD) (Ages =XX Years), Japan (2013-2023)
Table 25: Prevalent Cases of Growth Hormone Deficiency (GHD) By Sex (Males & Females), Japan (2013-2023)
Table 26: Prevalent Cases By Growth Hormone Deficiency (GHD) Sub-population, Japan (2013-2023)

List of Chart

Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Growth Hormone Deficiency (GHD) Global Epidemiology, (2013-2023)
Figure 4: Prevalent Cases of Growth Hormone Deficiency (GHD) (Ages =XX Years), US (2013-2023)
Figure 5: Prevalent Cases of Growth Hormone Deficiency (GHD) By Sex (Males & Females), US (2013-2023)
Figure 6: Prevalent Cases By Growth Hormone Deficiency (GHD) Sub-population,US (2013-2023)
Figure 7: Prevalent Cases of Growth Hormone Deficiency (GHD) (Ages =XX Years), United Kingdom (2013-2023)
Figure 8: Prevalent Cases of Growth Hormone Deficiency (GHD) By Sex (Males & Females), United Kingdom (2013-2023)
Figure 9: Prevalent Cases By Growth Hormone Deficiency (GHD) Sub-population,United Kingdom (2013-2023)
Figure 10: Prevalent Cases of Growth Hormone Deficiency (GHD) (Ages =XX Years), Germany (2013-2023)
Figure 11: Prevalent Cases of Growth Hormone Deficiency (GHD) By Sex (Males & Females), Germany (2013-2023)
Figure 12: Prevalent Cases By Growth Hormone Deficiency (GHD) Sub-population,Germany (2013-2023)
Figure 13: Prevalent Cases of Growth Hormone Deficiency (GHD) (Ages =XX Years), France (2013-2023)
Figure 14: Prevalent Cases of Growth Hormone Deficiency (GHD) By Sex (Males & Females), France (2013-2023)
Figure 15: Prevalent Cases By Growth Hormone Deficiency (GHD) Sub-population,France (2013-2023)
Figure 16: Prevalent Cases of Growth Hormone Deficiency (GHD) (Ages =XX Years), Italy (2013-2023)
Figure 17: Prevalent Cases of Growth Hormone Deficiency (GHD) By Sex (Males & Females), Italy (2013-2023)
Figure 18: Prevalent Cases By Growth Hormone Deficiency (GHD) Sub-population,Italy (2013-2023)
Figure 19: Prevalent Cases of Growth Hormone Deficiency (GHD) (Ages =XX Years), Spain (2013-2023)
Figure 20: Prevalent Cases of Growth Hormone Deficiency (GHD) By Sex (Males & Females), Spain (2013-2023)
Figure 21: Prevalent Cases By Growth Hormone Deficiency (GHD) Sub-population,Spain (2013-2023)
Figure 22: Prevalent Cases of Growth Hormone Deficiency (GHD) (Ages =XX Years), Japan (2013-2023)
Figure 23: Prevalent Cases of Growth Hormone Deficiency (GHD) By Sex (Males & Females), Japan (2013-2023)
Figure 24: Prevalent Cases By Growth Hormone Deficiency (GHD) Sub-population,Japan (2013-2023)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *